These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Influence of higher than conventional doses of oxitropium bromide on formoterol-induced bronchodilation in COPD. Cazzola M, Matera MG, Di Perna E, Califano C, D'Amato M, Mazzarella G. Respir Med; 1999 Dec; 93(12):909-11. PubMed ID: 10653054 [Abstract] [Full Text] [Related]
7. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists. van der Woude HJ, Winter TH, Aalbers R. Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351 [Abstract] [Full Text] [Related]
8. Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease. Cazzola M, D'Amato M, Califano C, Di Perna F, Calderaro E, Matera MG, D'Amato G. Clin Ther; 2002 Apr; 24(4):595-604. PubMed ID: 12017404 [Abstract] [Full Text] [Related]
9. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease. Cazzola M, Centanni S, Boveri B, Di Marco F, Santus P, Matera MG, Allegra L. Respiration; 2001 Apr; 68(5):452-9. PubMed ID: 11694805 [Abstract] [Full Text] [Related]
10. Effect of salmeterol and formoterol in patients with chronic obstructive pulmonary disease. Cazzola M, Santangelo G, Piccolo A, Salzillo A, Matera MG, D'Amato G, Rossi F. Pulm Pharmacol; 1994 Apr; 7(2):103-7. PubMed ID: 7915921 [Abstract] [Full Text] [Related]
11. Bronchodilator effect of an inhaled combination therapy with salmeterol + fluticasone and formoterol + budesonide in patients with COPD. Cazzola M, Santus P, Di Marco F, Boveri B, Castagna F, Carlucci P, Matera MG, Centanni S. Respir Med; 2003 May; 97(5):453-7. PubMed ID: 12735659 [Abstract] [Full Text] [Related]
13. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease. Jarvis B, Markham A. Drugs Aging; 2001 May; 18(6):441-72. PubMed ID: 11419918 [Abstract] [Full Text] [Related]
14. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol. Lipworth BJ, Aziz I. J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190 [Abstract] [Full Text] [Related]
15. Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil Aerolizer) with salbutamol (Ventodisk). Benhamou D, Cuvelier A, Muir JF, Leclerc V, Le Gros V, Kottakis J, Bourdeix I. Respir Med; 2001 Oct; 95(10):817-21. PubMed ID: 11601748 [Abstract] [Full Text] [Related]
16. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease. Ikeda A, Nishimura K, Koyama H, Izumi T. Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652 [Abstract] [Full Text] [Related]